Clinical Trial

Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy

Study acronym: CEMC
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of current study is to: Evaluate the cardioprotective effects of melatonin in patients with cardiomyopathy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-19; most recent amendment 2025-03-22.
Status change: Not Yet Recruiting → Recruiting 2025-02-26
Trial Details
NCT Number NCT06846086
Lead Sponsor Tanta University
Conditions Cardiomyopathies
Enrollment 46 participants
Start Date 2025-02-20
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-26